November 4th, 2010
From Michael Yang, General Manager, Veridex
Last year, the Veridex team met Jesica Harrington, a young mother and fifth grade teacher from Castle Rock, Colorado. Jesica’s story as a breast cancer survivor, mother and advocate for others fighting this disease inspires us and makes us proud to be part of an organization that is changing the way we think about managing cancer.
Jesica is one of 2.5 million breast cancer survivors living in the United States. Further complicating an already devastating diagnosis was the fact that she was pregnant at the time she was diagnosed with the disease.
As we described in Johnson & Johnson’s 2009 annual report, Jesica learned about the CELLSEARCH®Circulating Tumor Cell (CTC) Test, a blood test to capture and detect CTCs, from her father, and she and her doctor made the decision to use the test as a tool that helped to determine her prognosis during her treatment regimen.
Today, a year after she finished treatment, Jesica is cancer-free and is celebrating the birth of a healthy baby boy. Based on her experience battling the disease, she is sharing her story in the hope that other women will understand the power of knowledge in the fight against cancer.